Current reviews of allergy and clinical immunology: Drug metabolism, danger signals, and drug-induced hypersensitivity

Journal of Allergy and Clinical Immunology

Volumn 108, Issue 4, 2001, Pages 475-488

  Gruchalla, Rebecca S ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Adverse drug reactions; Allergic drug reactions; Danger hypothesis; Drug determinants; Drug metabolism

Indexed keywords

ALCURONIUM; AMOXICILLIN; ANTICONVULSIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFALEXIN; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; DAPSONE; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; PENICILLIN DERIVATIVE; SULFAMETHOXAZOLE; SUXAMETHONIUM; THIOPENTAL; TUBOCURARINE CHLORIDE; ANTIINFECTIVE AGENT; LACTAM; SULFONE;

ALGORITHM; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; CLINICAL PRACTICE; DESENSITIZATION; DRUG HYPERSENSITIVITY; DRUG INDUCED DISEASE; DRUG METABOLISM; DRUG PROTEIN BINDING; DRUG STRUCTURE; HUMAN; IMMUNE RESPONSE; IMMUNOPHARMACOLOGY; PRIORITY JOURNAL; REVIEW; TREATMENT PLANNING; BIOLOGICAL MODEL; IMMUNOLOGY;

ANTI-BACTERIAL AGENTS; ANTIGEN PRESENTATION; DRUG HYPERSENSITIVITY; IMMUNOGLOBULIN E; IMMUNOGLOBULINS, INTRAVENOUS; LACTAMS; MODELS, IMMUNOLOGICAL; SULFONES;

EID: 0034774826     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2001.118509     Document Type: Article

References (109)

1. Drug-related hospital admissions
2. Incidence of adverse drug events and potential adverse drug events. Implications for prevention
3. The costs of adverse drug events in hospitalized patients
4. Adverse drug events in hospitalized patients. Excess length of stay, extra costs and attributable mortality
5. Adverse drug reactions
6. Recent clinical and immunological aspects of penicillin allergy
7. Immunochemical mechanisms of drug allergy
8. Drug allergy
9. Identification of penicillin allergenic determinants that bind IgE antibodies in the sera of subjects with penicillin allergy
10. Beta-lactam drug allergens: Fine structural recognition patterns of cephalosporin-reactive IgE antibodies
11. Penicillins and cephalosporins as allergens: Structural aspects of recognition and cross-reactions
12. Diagnosis of allergy to penicillins and cephalosporins: Structural and immunochemical considerations
13. Detection of serum IgE antibodies that react with alcuronium and tubocurarine after life-threatening reactions to muscle-relaxant drugs
14. Anaphylaxis to muscle relaxant drugs: Cross-reactivity and molecular basis of binding of IgE antibodies detected by radioimmunoassay
15. Allergy to thiopentone
16. Mechanisms in IgE-dependent anaphylaxis to anaesthetic drugs
17. Detection of IgE antibodies to suxamethonium after anaphylactoid reactions during anaesthesia
18. Detection of thiopentone-reactive IgE antibodies following anaphylactoid reactions during anaesthesia
19. Drugs as allergens: Detection and combining site specificities of IgE antibodies to sulfamethoxazole
20. Immunologic mechanisms of penicillin allergy. A haptenic model system for the study of allergic disease in man
21. Penicillin allergy: The formation of the penicilloyl determinant
22. Chemistry of drug allergenicity
23. Diagnosis of allergy to penicillins and cephalosporins. Structural and immunochemical considerations
24. In vitro reactivity of penicilloyl and penicillanyl albumin and polylysine conjugates with IgE antibody
25. Drugs as allergens: An immunoassay for detecting IgE antibodies to cephalosporins
26. Penicillins and cephalosporins as allergens - Structural aspects of recognition and cross-reactions
27. Allergy to semisynthetic penicillins in cystic fibrosis
28. New aspects of allergic reactions to betalactams: Crossreactions and unique specificities
29. Immediate allergic reactions to cephalosporins: Cross-reactivity and selective responses
30. Molecular mechanisms of CD8+ T cell-mediated delayed hypersensitivity: Implications for allergies, asthma, and autoimmunity
31. Studies on the sensitization of animals with simple compounds
32. Allergic and autoimmune reactions to xenobiotics: How do they arise?
33. Role of drug disposition in drug hypersensitivity: A chemical, molecular and clinical perspective
34. Metabolic basis of adverse drug reactions
35. Drug disposition and drug hypersensitivity
36. The role of leukocyte-generated reactive metabolites in the pathogenesis of idiosyncratic drug reactions
37. Advances in molecular toxicology - Towards understanding idiosyncratic drug toxicity
38. Idiosyncratic drug reactions: Metabolic bioactivation as a pathogenic mechanism
39. Allergic reactions to drugs and biologic agents
40. Drug allergy
41. Metabolic predisposition to cutaneous drug reactions: Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants
42. The role of reactive drug metabolites in immune-mediated adverse drug reactions
43. Idiosyncratic drug reactions: A mechanistic evaluation of risk factors
44. Anticonvulsant hypersensitivity syndrome: In vitro assessment of risk
45. Diagnosis of sulfonamide hypersensitivity reactions by in vitro rechallenge with hydroxylamine metabolites of sulfonamides
46. Sulfonamide-induced reactions in patients with AIDS: Role of covalent protein haptenation
47. Allergic reactions to drugs
48. Cellular disposition of sulphamethoxazole and its metabolites: Implications for hypersensitivity
49. Cutaneous cytochrome P-450
50. Multiple cytochrome P450 isozymes in murine skin: Induction of P450 1A, 2B. 3E, and 3A by dexamethasone
51. A role for bioactivation and covalent binding within epidermal keratinocytes in sulfonamide-induced cutaneous drug reactions
52. Dendritic cells and the control of immunity
53. Rapid generation of broad T-cell immunity in humans after a single injection of mature dendritic cells
54. Cytotoxicity is mandatory for CD8+ T cell-mediated contact hypersensitivity
55. Stimulation of penicillin-sensitive lymphocytes by antigenic determinants covalently bound to cell membranes
56. Heterogeneous T cell responses to beta-lactam-modified self-structures are observed in penicillin-allergic individuals
57. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfonamides, phenytoin and carbamazepine
58. T cell recognition of penicillin G: Structural features determining antigenic specificity
59. Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy
60. Enrichment and function of urushiol (poison-ivy)-specific T lymphocytes in lesions of allergic contact dermatitis to urushiol
61. Isolation and characterization of Ni-specific T-cell clones from patients with Ni-contact dermatitis
62. Antigen specific human T-cell lines specific for cobalt chloride
63. Processing of Urushiol (poison ivy) hapten by both endogenous and exogenous pathways for presentation to T cells in vitro
64. MHC-dependent and -independent activation of human nickel-specific CD8+ cytotoxic T cells from allergic donors
65. Direct MHC-dependent presentation of the drug sulfamethoxazole to human alpha/beta T cell clones
66. HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes
67. Recognition of sulfamethoxazole and its reactive metabolites by drug-specific CD4+ T cells from allergic individuals
68. Selective generation of CD8+ T-cell clones from the peripheral blood of patients with cutaneous reactions to beta-lactam antibiotics
69. Predominance of epidermal CD8+ T lymphocytes in bullous cutaneous reactions caused by beta-lactam antibiotics
70. Cross-reactivity of T cell lines and clones to beta-lactam antibiotics
71. Peroxidase-dependent oxidation of sulfonamides by monocytes and neutrophils from humans and dogs
72. In vitro evaluation of a toxic metabolite of sulfadiazine
73. Reactions of the nitroso and hydroxylamine metabolites of sulfamethoxazole with reduced glutathione
74. Expression of monomorphic arylamine N-acetyltransferase (NAT1) in human leukocytes
75. Sulfonamide-reactive lymphocytes detected at very low frequency in the peripheral blood of patients with drug-induced eruptions
76. Role of T cells in drug allergies
77. CD8+ dermal T cells from a sulphamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes
78. T-cell-mediated cytotoxicity against keratinocytes in sulfamethoxazole-induced skin reaction
79. Infiltration of cytotoxic T cells in drug-induced cutaneous eruptions
80. Immunochemical analysis of sulfonamide drug allergy: Identification of sulfamethoxazole-substituted human serum proteins
81. Approaching the asymptote? Evolution and revolution in immunology
82. The immune system evolved to discriminate infectious non-self from noninfectious self
83. Tolerance, danger, and the extended family
84. An innate sense of danger
85. New concepts in immunology relevant to idiosyncratic drug reactions: The "Danger Hypothesis" and innate immune system
86. Metabolic activation in drug allergies
87. Inflammatory cytokines provide a third signal for activation of naive CD4+ and CD8+ T cells
88. Immunological tolerance: Danger-pathogen on the premises!
89. Langerhans cells require signals from both tumour necrosis-alpha and interleukin-1 beta for migration
90. Characterization of chemical allergens as a function of divergent cytokine secretion profiles induced in mice
91. Contribution of CD4+ and CD8+ T lymphocytes to the cytokine secretion patterns induced in mice during sensitization to contact and respiratory chemical allergens
92. Subjects with allergic reactions to drugs show in vivo polarized patterns of cytokine expression depending on the chronology of the clinical reaction
93. Eosinophil activation and in situ interleukin-5 production by mononuclear cells in skin lesions of patients with drug hypersensitivity
94. Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions
95. Lymphocyte activation in cutaneous drug reactions
96. IL-4 and IFN-gamma mRNA induction in human peripheral lymphocytes specific for beta-lactam antibiotics in immediate or delayed hypersensitivity reactions
97. Highly Th2-skewed cytokine profile of beta-lactam-specific T cells from nonatopic subjects with adverse drug reactions
98. Antigenicity and immunogenicity of sulphamethoxzaole: Demonstration of metabolism-dependent haptenation and T-cell proliferation in vivo
99. Clinical assessment of drug-induced disease
100. Disease management of drug hypersensitivity: A practice parameter
101. Determination of nonirritating skin test concentrations of commonly-used antimicrobial drugs
102. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy
103. Under-reporting of antibiotic anaphylaxis may put patients at risk
104. Beta-lactam crossreactivity
105. Structural determinants of antibiotic allergy
106. Evaluation of adverse cutaneous reactions to aminopenicillins with emphasis on those manifested by maculopapular rashes
107. A diagnostic protocol for evaluating nonimmediate reactions to aminopenicillins
108. Penicillin allergy: Prevalence of vague history in skin test-positive patients
109. Diagnosing cutaneous adverse reactions to drugs